Stock listing
CGEN Stock Price, News, Filings & Events — Compugen Ltd.
Selected listing: CGEN · NASDAQ · USD · US
This page tracks Compugen Ltd.'s CGEN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGEN:NASDAQ. CGEN:NASDAQ is the stock-level entry point for investors researching Compugen Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Compugen Ltd. is a public company traded under the ticker CGEN in the American market. The company has a market capitalization of approximately $224 million. Compugen focuses on developing innovative therapeutic solutions in the field of immuno-oncology.
- Ticker
- CGEN:NASDAQ
- Asset type
- Stock
- Market cap
- $247.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Compugen Ltd. CGEN:NASDAQ stock context
This page tracks Compugen Ltd.'s CGEN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGEN:NASDAQ. CGEN:NASDAQ is the stock-level entry point for investors researching Compugen Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Compugen Ltd. is a public company traded under the ticker CGEN in the American market. The company has a market capitalization of approximately $224 million. Compugen focuses on developing innovative therapeutic solutions in the field of immuno-oncology.
Latest news from Compugen Ltd.
Compugen Reports Second Quarter 2026 Results
August 3, 2026
Compugen to Participate in BTIG Biotechnology Conference 2026
July 21, 2026
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
July 20, 2026
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
June 18, 2026
Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
June 11, 2026
Compugen Ltd. earnings calls
Compugen Ltd. (CGEN) Q2 2026 Earnings Call
August 3, 2026 · Replay with transcript and chapters
Compugen Ltd. (CGEN) Q1 2026 Earnings Call
May 18, 2026 · Replay with transcript and chapters
Compugen Ltd. (CGEN) Q4 2025 Earnings Call
March 2, 2026 · Replay with transcript and chapters
Compugen Ltd. (CGEN) Q3 2025 Earnings Call
November 20, 2025 · Replay with transcript and chapters
Compugen Ltd. (CGEN) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Compugen Ltd. (CGEN) Q1 2025 Earnings Call
May 19, 2025 · Replay with transcript and chapters
Research Compugen Ltd.
Compugen Ltd. investor report
Review AI stock analysis and investor report context for CGEN:NASDAQ.
Compugen Ltd. company profile
View the public company page for Compugen Ltd. on 6ix.
Compugen Ltd. news
Read company news and market updates connected to Compugen Ltd..
Compugen Ltd. investor events
Find investor webinars, events, and replay context for Compugen Ltd..
Alternate listings
CGEN:TASE
IL · ILA
Alternate listing for Compugen Ltd.; the primary context on this page is CGEN:NASDAQ.
CGEN:BOATS
US · USD
Alternate listing for Compugen Ltd.; the primary context on this page is CGEN:NASDAQ.
CW9:TRADEGATE
DE · EUR
Alternate listing for Compugen Ltd.; the primary context on this page is CGEN:NASDAQ.